Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Department of Nursing, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran.
Complement Ther Med. 2019 Apr;43:92-101. doi: 10.1016/j.ctim.2019.01.002. Epub 2019 Jan 9.
There is some evidence regarding the positive effects of cinnamon on metabolic status in patients with type 2 diabetes (T2DM). However, they are conflicting. In the present study, we aimed to systematically review the effects of cinnamon on glycemic status and anthropometric indices in patients with T2DM.
Five electronic databases including PubMed/Medline, SCOPUS, Web of Sciences, EMBASE, and the Cochrane library were searched until 31 February 2018 with no language limitation. Randomized clinical trials that examined the effects of cinnamon on at least fasting blood sugar (FBS) were included. Other glycemic parameters and anthropometric indices were also extracted. A random effects model with DerSimonian and Laird method was used for pooling the effect sizes.
Finally, 18 studies were included in the meta-analysis. Supplementation with cinnamon reduced FBS by -19.26 mg/dL (95% CI: -28.08, -10.45; I:96.5%; p = 0.0001) compared to placebo. However, the effects of cinnamon on HbA1C (-0.24%; 95% CI: -0.48, -0.01; I: 76.8%, p = 0.0001), body weight (-0.46, 95%CI: -1.87, 2.30; I:0%; p = 0.79), body mass index (WMD: -0.05 kg/m2; 95% CI: -0.52, 0.42; I: 0%; p = 0.91), and waist circumference (WMD: -0.53 cm; 95% CI: -3.96, 2.81; I: 0%; p = 0.66) were not significant. Additionally, cinnamon did not change the serum levels of insulin and insulin resistance significantly.
Supplementation with cinnamon can reduce serum levels of glucose with no changes in other glycemic parameters and anthropometric indices. However, due to high heterogeneity findings should be interpreted with great caution.
有一些证据表明肉桂对 2 型糖尿病(T2DM)患者的代谢状况有积极影响。然而,这些证据相互矛盾。本研究旨在系统评价肉桂对 T2DM 患者血糖状态和人体测量学指标的影响。
检索了 PubMed/Medline、SCOPUS、Web of Sciences、EMBASE 和 Cochrane 图书馆五个电子数据库,截至 2018 年 2 月 31 日,无语言限制。纳入了评估肉桂对空腹血糖(FBS)至少有影响的随机临床试验。还提取了其他血糖参数和人体测量学指标。使用具有 DerSimonian 和 Laird 方法的随机效应模型来汇总效应大小。
最终,18 项研究纳入荟萃分析。与安慰剂相比,肉桂补充剂可使 FBS 降低-19.26mg/dL(95%CI:-28.08,-10.45;I:96.5%;p=0.0001)。然而,肉桂对糖化血红蛋白(HbA1C)(-0.24%;95%CI:-0.48,-0.01;I:76.8%,p=0.0001)、体重(-0.46,95%CI:-1.87,2.30;I:0%;p=0.79)、体重指数(WMD:-0.05kg/m2;95%CI:-0.52,0.42;I:0%;p=0.91)和腰围(WMD:-0.53cm;95%CI:-3.96,2.81;I:0%;p=0.66)的影响无统计学意义。此外,肉桂对血清胰岛素和胰岛素抵抗水平没有显著影响。
肉桂补充剂可降低血糖水平,而其他血糖参数和人体测量学指标无变化。然而,由于存在高度异质性,结果应谨慎解释。